Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation

Patent metadata

Field	Value
Publication number	US-9757494-B2
Application number	US-201514728412-A
Country	US
Kind code	B2
Filing date	Jun 2, 2015
Priority date	Aug 31, 2010
Publication date	Sep 12, 2017
Grant date	Sep 12, 2017

Abstract

The present invention relate to three dimensional porous polysaccharide matrices able to induce mineralisation of a tissue in osseous site, as well as in non-osseous site, in the absence of stent cells or growth factors.

First claim

The invention claimed is:

1. A method for bone generation at an osseous or a non-osseous site, comprising the step of administering, at the osseous or the non-osseous site, a porous polysaccharide scaffold obtained by
i) preparing an alkaline aqueous solution comprising at least one polysaccharide, a cross-linking agent and a porogen agent,
ii) transforming the solution into a hydrogel by placing said solution at a temperature from 4° C. to 80° C. for a sufficient time to allow cross-linking of said at least one polysaccharide,
iii) submerging said hydrogel into a solvent, and
iv) washing the porous polysaccharide scaffold obtained at step iii), wherein the alkaline aqueous solution of step i) further comprises hydroxyapatite, and wherein the step of administering is performed in the absence of cells and growth factors.

2. The method according to claim 1 , wherein said porous polysaccharide scaffold is administered to a non-osseous site.

3. The method according to claim 1 , wherein the porogen agent is selected from the group consisting of sodium chloride, calcium chloride, ammonium carbonate, ammonium bicarbonate, calcium carbonate, sodium carbonate, sodium bicarbonate and mixtures thereof.

4. The method according to claim 1 , wherein a weight ratio of the at least one polysaccharide to the porogen agent is in a range from 1:50 to 50:1.

5. The method according to claim 1 , wherein said at least one polysaccharide is selected from the group consisting of dextran, pullulan, agar, alginic acid, starch, hyaluronic acid, inulin, heparin, fucoidan, chitosan and mixtures thereof.

6. The method according to claim 1 , wherein said at least one polysaccharide is a mixture of pullulan/dextran in a ratio in a range from 95:5 to 5:95.

7. The method according to claim 1 , wherein said at least one polysaccharide is a mixture of pullulan/dextran/fucoidan in a ratio in a range from 70:20:10 to 50:20:30.

8. The method according to claim 7 , wherein said ratio is selected from the group consisting of 70:20:10 (w/w), 50:30:20 (w/w), and 73:22:5 (w/w).

9. The method according to claim 1 , wherein said cross-linking agent is selected from the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl 3 ), epichlorohydrin, formaldehydes, carbodiimides, glutaraldehydes, and mixtures thereof.

10. The method according to claim 1 , wherein said hydroxyapatite is nano-hydroxyapatite.

11. The method according to claim 10 , wherein said nano-hydroxyapatite is obtained from a solution of phosphoric acid at a concentration between 0.3 to 1M, with a solution of calcium hydroxide at a concentration between 0.5 to 1.5M, through chemical precipitation at room temperature.

12. The method according to claim 11 , wherein said phosphoric acid concentration is 0.6M and said calcium hydroxide concentration is 1M.

13. The method according to claim 10 , wherein a concentration of nano-hydroxyapatite in the alkaline aqueous solution is between 0.01 and 10% (w/v).

14. The method of claim 13 , wherein said nano-hydroxide concentration is between 0.1 and 0.5% (w/v) or between 0.1 and 0.3% (w/v).

15. The method according to claim 1 , wherein said porous polysaccharide scaffold contains pores from 1 μm to 500 μm in size and the porosity is from 4% to 75%.

16. The method of claim 15 , wherein the pores are from 10 to 200 μm in size and the porosity is from 4% to 50%.

17. The method according to claim 1 , wherein said solvent is an aqueous solution.

18. The method according to claim 1 , wherein a weight ratio of the at least one polysaccharide to said porogen agent is in a range from 1:30 to 30:1 (w/w).

19. The method according to claim 18 , wherein said weight ratio is 75:25 (w/w).

20. A method for bone generation at an osseous or a non-osseous site comprising the step of administering, at the osseous or the non-osseous site, a porous polysaccharide scaffold obtained by:
a) preparing an alkaline aqueous solution comprising at least one polysaccharide, and one cross-linking agent,
b) freezing the aqueous solution of step a), and
c) sublimating the frozen solution of step b),
wherein the alkaline aqueous solution of step a) further comprises hydroxyapatite,
and wherein step b) is performed before cross-linking of the polysaccharide occurs in the solution of step a),
and wherein the step of administering is performed in the absence of cells and growth factors.

Assignees

• Amedee Joelle
• Letourneur Didier
• Le Visage Catherine
• Derkaoui Sidi Mohammed
• Fricain Jean-Christophe
• Catros Sylvain
• Inst Nat De La Sante Et De La Rech Medicale (Inserm)
• Univ De Bordeaux Ii Victor Segalen
• Univ Paris Diderot-Paris 7

Inventors

• Amedee Joelle
• Letourneur Didier
• Le Visage Catherine
• Derkaoui Sidi Mohammed
• Fricain Jean-Christophe
• Catros Sylvain

Classifications

• A61L27/12 Primary

  Phosphorus-containing materials, e.g. apatite · CPC title

• C08J2205/022

  Hydrogel, i.e. a gel containing an aqueous composition · CPC title

• A61L2400/12

  Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces · CPC title

• C08J2201/0484

  the liquid phase being aqueous · CPC title

• C08J9/28

  by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum · CPC title